Page last updated: 2024-12-05

tetramethoxysilane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Tetramethoxysilane (TMOS) is a colorless liquid with a pungent odor. It is a common precursor to silica, and is used in a variety of applications including sol-gel processing, coatings, and adhesives. TMOS is typically synthesized by reacting silicon tetrachloride with methanol in the presence of a base catalyst. The hydrolysis and condensation reactions of TMOS are well-studied, and are the basis for its use in sol-gel processing. In sol-gel processing, TMOS is hydrolyzed to form a silica sol, which can then be condensed to form a silica gel. The properties of the silica gel can be controlled by varying the conditions of the hydrolysis and condensation reactions. TMOS is also used in the production of silica coatings, which can provide protection against corrosion, wear, and abrasion. It is also used in the production of adhesives, which can be used to bond various materials together. The importance of TMOS stems from its ability to be used as a precursor to silica, which is a versatile and useful material. Silica is used in a wide variety of applications, including glass, ceramics, and electronics. The study of TMOS and its reactions is important for understanding the chemistry of silica and for developing new applications for this material.'

Cross-References

ID SourceID
PubMed CID12682
CHEMBL ID3183859
SCHEMBL ID17814
MeSH IDM0169772

Synonyms (71)

Synonym
tetra-methyl orthosilicate
tmos
sit 7510.0
msp 150
methyl silicate, ((meo)4si)
einecs 211-656-4
un2606
tetramethylsilikat [czech]
nsc 67383
ai3-11596
methyl silicate 39
methyl silicate 56
tsl 8114
methyl silicate 28
hsdb 5511
tetramethylsilikat
ec 211-656-4
methyl orthosilicate [un2606] [poison]
19d35vpl66 ,
unii-19d35vpl66
LS-13029
wln: 1o-si-o1&o1&o1
silicic acid, methyl ester of ortho-
tetramethyl silicate
tl 190
tetramethoxysilane ,
681-84-5
methyl silicate
methyl silicate ((ch3)4sio4)
silicic acid, tetramethyl ester
nsc-67383
nsc67383
tetramethyl orthosilicate
silicic acid (h4sio4), tetramethyl ester
methyl orthosilicate
methyl silicate ((meo)4si)
silane, tetramethoxy-
tetramethyl orthosilicate, deposition grade, >=98%, >=99.9% trace metals basis
tetramethyl orthosilicate, >=99%
tetramethyl orthosilicate, 98%
T0588
A836042
NCGC00248830-01
NCGC00258334-01
tox21_200780
dtxsid3027291 ,
cas-681-84-5
dtxcid207291
FT-0689080
S15925
AKOS015902512
tetramethyl ester silicate
tetramethyl silicate [hsdb]
tetramethoxy-silane
si(ome)4
tetramethylorthosilicate
tetramethoxy silane
tetramethylortho silicate
tetramethylortho-silicate
si(och3)4
SCHEMBL17814
un 2606
dynasil m
CHEMBL3183859
J-524888
tetramethyl orthosilicate, purum, >=98.0% (gc)
tetramethyl orthosilicate, puriss., >=99.0% (gc)
mfcd00008341
F0001-1787
Q377159
EN300-395310

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The data of this study showed that TMOS has a steep dose-response curve with no observable effects at 10 ppm, very minimal effects at 15 ppm, moderate to severe effects at 30 ppm, and severe effects and lethality at 45 ppm."( Subchronic inhalation toxicity of tetramethoxysilane in rats.
Geil, RG; Hobbs, EJ; Kolesar, GB; Malczewski, RM; Siddiqui, WH, 1989
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency47.37500.000221.22318,912.5098AID743042
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency66.91900.000323.4451159.6830AID743065; AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.39)18.7374
1990's2 (2.78)18.2507
2000's33 (45.83)29.6817
2010's34 (47.22)24.3611
2020's2 (2.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.08 (24.57)
Research Supply Index4.33 (2.92)
Research Growth Index5.99 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other74 (98.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]